TXMD icon

TherapeuticsMD

168 hedge funds and large institutions have $467M invested in TherapeuticsMD in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.01% less ownership

Funds ownership: 1.43%1.42% (-0.01%)

26% less capital invested

Capital invested by funds: $627M → $467M (-$160M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
168
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.33M
Puts
$2.4M
Net Calls
Net Calls Change

Top Buyers

1 +$10M
2 +$9.52M
3 +$5.45M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.78M
5
JGC
J. Goldman & Co
New York
+$4.45M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$260K
77
$253K
78
$253K
79
$250K
80
$245K
81
$244K
82
$243K
83
$225K
84
$222K
85
$215K
86
$202K
87
$189K
88
$181K
89
$177K
90
$148K
91
$133K
92
$128K
93
$125K
94
$118K
95
$110K
96
$109K
97
$107K
98
$101K
99
$98K
100
$98K